pharmaphorum

NOVEMBER 19, 2020

The coronavirus vaccine being developed by Oxford University and AstraZeneca produces a strong immune response in higher risk older patients, a study has found. The post Encouraging data from AZ/Oxford coronavirus shot appeared first on. Booster regimes were given 28 days apart and dosing regimen varied according to age group.

Vaccines 100

Vaccines Immunization FDA 100

pharmaphorum

AUGUST 18, 2020

million euro project funded by European Union cash and European pharma companies is a work stream that aims to find drugs that work against coronavirus strains that may emerge in the future. The trick is to look for proteins that are used across all coronavirus types and tend not to vary much from one virus species to another.

96

96

pharmaphorum

SEPTEMBER 30, 2020

Regeneron’s antibody cocktail seems to reduce levels of coronavirus and improve symptoms in patients, according to early test results. The post Regeneron’s antibody cocktail active against coronavirus, cuts symptoms appeared first on.

Immunization 135

Immunization 135

pharmaphorum

AUGUST 14, 2020

Catch up on the latest coronavirus vaccine and digital tech news in our roundup of this week’s biggest stories. Russia has become the first country in the world to approve a coronavirus vaccine , amid scepticism from international experts who have been unable to review or verify clinical data from the jab called ‘Sputnik V’.

Vaccines 87

Vaccines Hospitals 87

pharmaphorum

AUGUST 11, 2020

Russia has become the first country in the world to approve a coronavirus vaccine, amid scepticism from international experts who have been unable to review or verify clinical data from the jab called ‘Sputnik V’ According to press reports the vaccine has been tested on one of President Vladimir Putin’s daughters.

Vaccines 97

Vaccines Immunization 97

pharmaphorum

MAY 10, 2021

Coronavirus won’t be circulating in the UK by August, according to the outgoing chief of the country’s vaccine rollout scheme, Dr Clive Dix. He told the newspaper that the country is on track to meet its target of giving at least one shot of coronavirus vaccine to all adults by the end of July.

Vaccines 114

Vaccines 114

pharmaphorum

OCTOBER 14, 2020

There is growing evidence that the coronavirus may be able to re-infect patients, and a new instance of a second infection has been confirmed in the US. . It’s the first such case to emerge with the coronavirus, although sudden hearing loss can follow other viral infections including flu.

Immunization 95

Immunization Hospitals 95

pharmaphorum

SEPTEMBER 14, 2020

AstraZeneca has resumed UK trials for its coronavirus vaccine, after the country’s medicines regulator gave the all-clear following a safety scare. The vaccine is top of the list of 35 potential coronavirus vaccines in clinical development, according to a list maintained by the World Health Organization.

Vaccines 77

Vaccines Immunization 77

pharmaphorum

NOVEMBER 26, 2020

The UK’s pharma industry trade body has warned that Brexit could derail the government’s efforts to get coronavirus vaccines to the population, but welcomed other measures in this week’s spending review aimed at reviving the economy after the pandemic.

Vaccines 105

Vaccines Packaging 105

pharmaphorum

FEBRUARY 18, 2021

GlaxoSmithKline is expanding a coronavirus antibody collaboration with US biotech Vir, to include potential therapies for flu and other respiratory viruses. The first is an expansion of their current functional genomics collaboration to develop potential pan-coronavirus therapeutics to now include other respiratory virus targets.

85

85

pharmaphorum

MARCH 16, 2021

Roche has launched a new test that will help monitor emerging variants of the SARS-CoV-2 coronavirus. The post Roche launches test to monitor emerging coronavirus variants appeared first on. The company’s high-throughput polymerase chain reaction (PCR) test has also been CE Mark approved.

Vaccines 81

Vaccines 81

pharmaphorum

SEPTEMBER 4, 2020

Sanofi and GlaxoSmithKline have begun clinical trials of their coronavirus vaccine, as AstraZeneca expanded studies of its rival into Japan. The move brings the total number of coronavirus vaccines in development across the world to 34, according to a regularly updated list maintained by the World Health Organization.

Vaccines 81

Vaccines Immunization 81

pharmaphorum

DECEMBER 10, 2020

The US government’s coronavirus vaccine chief has said that Pfizer/BioNTech’s vaccine could carry a warning that it should be avoided by people who are prone to serious allergic reactions. The post Coronavirus vaccine may have allergy warning in US, says expert appeared first on.

Vaccines 80

Vaccines Documentation FDA 80

pharmaphorum

JANUARY 20, 2021

UK biotech ConserV Bioscience has joined with California’s Lawrence Livermore National Laboratory to develop broad-spectrum coronavirus vaccines as concerns mount over potentially more infectious strains emerging in the UK, South Africa and Brazil. Feature image courtesy of Rocky Mountain Laboratories/NIH.

Vaccines 52

Vaccines Immunization 52

pharmaphorum

FEBRUARY 8, 2021

The post China approves Sinovac’s coronavirus vaccine appeared first on. The main target for the scheme will be developing countries as many high GDP nations have already snapped up hundreds of millions of doses each with their national vaccination schemes. Feature image courtesy of Rocky Mountain Laboratories/NIH.

Vaccines 64

Vaccines Immunization 64

pharmaphorum

AUGUST 13, 2020

million people – had been infected with coronavirus by the end of June according to an estimate based on antibody tests. Key workers in care homes and health care were among those most likely to have already been infected with the coronavirus. people infected with coronavirus in England – study appeared first on.

64

64

Pharma Marketing Network

JUNE 12, 2020

Just like coronavirus, other diseases have a higher incidence in some locations than others – for example diabetes is far more prevalent in Alabama than it is Colorado. The post What Pharmaceutical Marketers Can Learn from the Coronavirus Response appeared first on Pharma Marketing Network. One-size-fits-all just doesn’t work.

Communication 75

Communication 75

Pharmaceutical Technology

APRIL 15, 2024

Discover ImmunityBio Inc's groundbreaking patent for a cross-reactive SARS-CoV2 vaccine targeting multiple variants. Learn how this innovative method boosts immune response and memory cells for enhanced protection.

Vaccines 59

Vaccines Immunization 59

pharmaphorum

AUGUST 21, 2020

Doctors have called for rules to be tightened on coronavirus antibody tests in the UK amid fears that false readings could put the public at risk. It’s not even known for sure that having antibodies against the SARS-CoV-2 coronavirus confers immunity. Feature image courtesy of Rocky Mountain Laboratories/NIH.

Documentation 60

Documentation Immunization 60

PhRMA

MARCH 20, 2023

Leveraging decades of research and investments in emerging technologies and scientific expertise, we dedicated ourselves to finding medical solutions to prevent, diagnose and treat those impacted by the coronavirus.

Vaccines 222

Vaccines 222

PharmaVoice

JANUARY 22, 2024

A new study shows that a universal vaccine would lead to huge financial and mortality wins during a pandemic, but development has been slow going.

Vaccines 52

Vaccines 52

pharmaphorum

APRIL 27, 2021

The announcement follows tragedy of the runaway coronavirus outbreak in India, where hospitals are overwhelmed. The post US to share 60m AZ coronavirus vaccines with rest of world appeared first on. There are also concerns that the while Western countries stockpile vaccines, the outbreak in India could spawn dangerous new variants.

Vaccines 52

Vaccines FDA Hospitals 52

Pharmaceutical Technology

JULY 7, 2023

Oncolytic Virus for Human Papillomavirus Associated Cancer, Human Papillomavirus Infections and Coronavirus Disease 2019 (COVID-19) is under clinical development by Blue Sky Immunotherapies and currently in Phase I for Cervical Intraepithelial Neoplasia (CIN).

40

40

Pharmaceutical Technology

JULY 7, 2023

Oncolytic Virus for Human Papillomavirus Associated Cancer, Human Papillomavirus Infections and Coronavirus Disease 2019 (COVID-19) is under clinical development by Blue Sky Immunotherapies and currently in Phase I for Cervical Intraepithelial Neoplasia (CIN).

40

40

STAT

MARCH 28, 2024

While an increasingly anxious world watched a new coronavirus spread across the globe in early 2020, veteran immunologist Rafi Ahmed quickly grasped that his field was about to experience something truly extraordinary.

Immunization 145

Immunization Vaccines 145

STAT

APRIL 18, 2024

Even as evidence grew that coronavirus-laced particles could linger in the air indoors and infect people nearby, and researchers raised the alarm about the risks this posed to health care workers and the general public, the WHO didn’t acknowledge that Covid was airborne until late 2021.

145

145

Fierce Pharma

MARCH 25, 2024

The four years since the start of the COVID-19 pandemic have yielded many advances against the coronavirus, including Moderna and Pfizer’s groundbreaking mRNA vaccines. |

Immunization 97

Immunization Vaccines FDA 97

Fierce Pharma

SEPTEMBER 26, 2023

As coronavirus concerns increase with the changing of the seasons, the most commonly used oral antiviral treatments are in the spotlight once again. | As coronavirus concerns increase with the changing of the seasons, the most commonly used oral antiviral treatments are in the spotlight once again.

94

94

Pharma Times

APRIL 6, 2021

Everyone in England, including those without symptoms, will be able to take a free rapid coronavirus test twice a week

26

26

Pharma Times

AUGUST 24, 2020

A 33-year-old man was infected twice with slightly different strains of coronavirus more than four months apart

36

36

Pharmacy Times

MAY 19, 2023

Nanoparticles could improve the solubility of drugs, aid in treatment escape from the immune system, and increase the half-life of drugs in the circulatory system against viral lung infections such as influenza, coronavirus, and respiratory syncytial virus.

Immunization 139

Immunization Vaccines 139

pharmaphorum

DECEMBER 20, 2023

The validity of the patent is at the heart of patent litigation between CureVac and fellow German biotech BioNTech and its partner Pfizer, claiming infringement by their Comirnaty coronavirus shot.

Vaccines 108

Vaccines 108

STAT

OCTOBER 2, 2023

Overcoming a lack of broader interest in their work and scientific challenges, Katalin Karikó and Drew Weissman made key discoveries about messenger RNA that enabled scientific teams to start developing the tool into therapies, immunizations, and — as the pandemic spread in 2020 — vaccines targeting the SARS-CoV-2 coronavirus.

Immunization 145

Immunization Vaccines 145

Pharma Times

JANUARY 10, 2024

The partnership will advance VTP-500 from early development to phase 2 clinical trials

Vaccines 45

Vaccines 45

STAT

JANUARY 25, 2024

LONDON — Two research centers that have been at the forefront of following the evolution of the SARS-CoV-2 coronavirus — one in the U.K. and one in South Africa — have teamed up on a partnership that they say will expand their efforts to track emerging disease threats around the world. The collaboration between the U.K.’s

132

132

STAT

FEBRUARY 28, 2024

A new study published Wednesday in the New England Journal of Medicine, which looks at how much cognition is impaired in the months after a coronavirus infection, shows that Covid-19’s impact can be measured in the equivalent of IQ points.

Hospitals 145

Hospitals 145

STAT

JULY 21, 2023

WASHINGTON – The White House on Friday launched its pandemic preparedness office, half a year after Congress instructed the administration to set up a new arm in the wake of the coronavirus pandemic. The creation of a pandemic preparedness office was one of the last major bipartisan pushes for Sen. Richard Burr (R-N.C.) He and Sen.

Packaging 98

Packaging 98